🚀 go-pugleaf

RetroBBS NetNews Server

Inspired by RockSolid Light RIP Retro Guy

Article View: be.science
Article #414

Cancer - Press Review (August 11, 2012) – Revue de presse (11 août 2012)

#414
From: SMW
Date: Sat, 11 Aug 2012 15:36
130 lines
6370 bytes
Cancer – Press Review  – Revue de Presse

Every week on http://marclacroixcancerblog.blogspot.com
Chaque semaine sur http://marclacroixcancerblog.blogspot.com




Press Review (August 11, 2012) – Revue de presse (11 août 2012)


Komen Foundation Leaders Step Down Amid Turbulent Year for
Organization‎‎
The founder and president join exodus from leading breast cancer
nonprofit following controversy.
By Seth Cline. In U.S. News & World Report
http://www.usnews.com/news/articles/2012/08/09/komen-foundation-leaders-step-down-amid-turbulent-year-for-organization

Amgen pancreatic cancer drug lacks efficacy, trial ends
Amgen Inc halted a late-stage trial of an experimental drug for
pancreatic cancer after independent reviewers concluded that it was
unlikely to significantly help patients.
Amgen said the trial of ganitumab, also known as AMG479, did not raise
any safety concerns. The company said it would also stop a separate
mid-stage trial of the drug.
In Chicago Tribune
http://www.chicagotribune.com/health/sns-rt-us-amgenbre8771g9-20120808,0,1054216.story

How Chemotherapy May Trigger Tumors' Resistance‎‎‎
The researchers, from Fred Hutchinson Cancer Research Center,
characterized the protein as an unfriendly “neighbor” that lives in
the same environment as cancer cells.
By Alexandra Sifferlin. In TIME
http://healthland.time.com/2012/08/07/how-chemotherapy-may-trigger-tumors-resistance/

Prostate Cancer Among African American Men Reaches 'Epidemic'
Proportions, Senate Says‎‎ ‎‎
Despite ongoing debate about the benefits of PSA testing for men at
risk for prostate cancer, and recent research on the best course of
treatment for those who have been diagnosed, the U.S. Senate passed a
resolution Thursday acknowledging that awareness and prevention of the
disease is as critical as it's ever been for African American men.
In Huffington Post
http://www.huffingtonpost.com/2012/08/03/prostate-cancer-african-american-men-epidemic-senate-says_n_1738391.html

Zaltrap: Colon Cancer Drug Approved By FDA‎
The U.S. Food and Drug Administration said on Friday that it had
approved the Sanofi SA and Regeneron Pharmaceuticals Inc drug Zaltrap
for patients with metastatic colorectal cancer whose tumors have
failed to respond to earlier treatment with chemotherapy.
By Ransdell Pierson. In Huffington Post
http://www.huffingtonpost.com/2012/08/07/zaltrap-colon-cancer-drug-fda-approved_n_1753114.html


Cancer : de prochains traitements issus de la mer‎
Certaines bactéries, éponges et micro-algues marines renferment des
molécules jamais observées auparavant et potentiellement utilisables
en chimiothérapie.
Par Anne Jeanblanc. Dans Le Point
http://www.lepoint.fr/chroniqueurs-du-point/anne-jeanblanc/cancer-de-prochains-traitements-issus-de-la-mer-07-08-2012-1493644_57.php

Cancer : la chimiothérapie pourrait être contre-productive‎‎
Une étude publiée dans la revue Nature Medicine pourrait changer
l'idée que l'on se fait de la chimiothérapie. Les chercheurs du Fred
Hutchinson Cancer Research Center de Seattle auraient en effet
découvert que celle-ci abîmerait des cellules saines, déclenchant chez
elles la production d'une protéine alimentant les tumeurs.
Dans MaxiSciences
http://www.maxisciences.com/cancer/cancer-la-chimiotherapie-pourrait-etre-contre-productive_art26069.html

La femme qui dit non à la Légion d'honneur de Cécile Duflot‎‎ ‎‎
Annie Thébaud-Mony, directrice de recherche honoraire à l’Inserm,
figurait sur la liste des trente promus sélectionnés par Cécile
Duflot, la ministre du Logement. Elle lui a écrit hier pour refuser sa
Légion d’honneur.Un geste destiné à attirer l’attention sur «
l’impunité qui, jusqu’à ce jour, protège les responsables de crimes
industriels ».
Dans Rue89
http://www.rue89.com/2012/08/05/la-femme-qui-dit-non-la-legion-dhonneur-de-cecile-duflot-234403

LEAD 1-Sanofi/Zaltrap-Feu vert de la FDA dans le cancer colorectal
Sanofi et son partenaire américain Regeneron ont annoncé vendredi
avoir obtenu un feu vert de l'autorité sanitaire américaine (FDA) pour
commercialiser le Zaltrap dans le traitement du cancer colorectal
métastatique
Dans Reuters
http://fr.reuters.com/article/frEuroRpt/idFRL6E8J3P0P20120803









Cancer Blog – Marc Lacroix – Le Blogue du Cancer
http://marclacroixcancerblog.blogspot.com










Marc Lacroix-Corman – InTextoResearch – Baelen  (08/2012)
Technical Details
Message-ID: <efc3f58c-9339-403f-88b5-1160816cee07@q3g2000vbc.googlegroups.com>
Path: arc1-ca.pugleaf.net!c10ni105286pbw.0!nntp.google.com!news2.google.com!postnews.google.com!q3g2000vbc.googlegroups.com!not-for-mail

Show Full Headers
Complete Article Headers
X-Google-Thread: f5500,20d2a30e2cf8b59a,start
X-Google-NewGroupId: yes
X-Google-Attributes: gida254ea4a8d,domainid0,public,usenet
X-Google-Language: ENGLISH,UTF8
Received: by 10.66.74.40 with SMTP id q8mr1124465pav.19.1344699473337;
        Sat, 11 Aug 2012 08:37:53 -0700 (PDT)
Path: arc1-ca.pugleaf.net!c10ni105286pbw.0!nntp.google.com!news2.google.com!postnews.google.com!q3g2000vbc.googlegroups.com!not-for-mail
From: SMW <scimedweb@mail.com>
Newsgroups: be.science
Subject: Cancer - Press Review (August 11, 2012) – Revue de presse (11 août 2012)
Date: Sat, 11 Aug 2012 08:36:23 -0700 (PDT)
Organization: http://groups.google.com
Lines: 130
Message-ID: <efc3f58c-9339-403f-88b5-1160816cee07@q3g2000vbc.googlegroups.com>
NNTP-Posting-Host: 81.247.1.154
Mime-Version: 1.0
X-Trace: posting.google.com 1344699473 31843 127.0.0.1 (11 Aug 2012 15:37:53 GMT)
X-Complaints-To: groups-abuse@google.com
NNTP-Posting-Date: Sat, 11 Aug 2012 15:37:53 +0000 (UTC)
Complaints-To: groups-abuse@google.com
Injection-Info: q3g2000vbc.googlegroups.com; posting-host=81.247.1.154; posting-account=jR3pwAkAAABfF7uqn-zMzWqez-yhPWKE
User-Agent: G2/1.0
X-HTTP-UserAgent: Mozilla/5.0 (Windows NT 5.1) AppleWebKit/537.1 (KHTML, like
 Gecko) Chrome/21.0.1180.75 Safari/537.1,gzip(gfe)
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: quoted-printable